Araştırma Makalesi

The Relationship Between Koos Classification and ADC-Post-Contrast Signal Intensity Values of Vestibular Schwannomas

Cilt: 6 Sayı: 3 9 Aralık 2021
PDF İndir
TR EN

The Relationship Between Koos Classification and ADC-Post-Contrast Signal Intensity Values of Vestibular Schwannomas

Abstract

Aim: To determine the interobserver reliability of the Koos classification which is used for grading vestibular schwannomas and to evaluate its correlation with Apperent Diffusion Coefficiency (ADC) and post contrast signal intensity values. Methods: Vestibular schwannomas were retrospectively scanned from picture archiving and communication system over a 4-year period. Koos grade of tumor was assessed by two radiologists blinded to the clinical and pathological data. Cohen’s Kappa was used to analyse interobserver agreement of Koos grade. The correlation between ADC, signal intensity measurements and Koos grade of tumors was analysed with Kendall’s tau b correlation coefficient. Results: 33 patients (21 females, mean age 52.6±16.6 years) with 34 vestibular schwannomas were included the study. The reliability analyses revealed excellent inter-observer agreement for ADC (ICC: 0.93, 95% CI: 0.87-0.97, p<0.001) and signal intensity (ICC: 0.98, 95% CI: 0.96-0.99, p<0.001) measurements. The percentage agreement for Koos grading was 97% (k= 0.96, p<0.001). A correlation was not found between the Koos grade and ADC (_τ_b: 0.18). Also signal intensity remained similar between Koos grades (p=0.125). A significant difference was found for ADC values between Koos grades (p=0.039). Conclusion: Koos classification is a practical and useful grading system with excellent interobserver agreement for vestibular schwannomas. ADC values differs significantly between the tumor grades, but ADC and post contrast signal intensity values have no correlation with Koos grade.

Keywords

Destekleyen Kurum

no funding

Kaynakça

  1. 1. Lin D, Hegarty JL, Fischbein NJ, Jackler RK. The prevalence of "incidental" acoustic neuroma. Arch Otolaryngol Head Neck Surg. 2005 Mar; 131(3):241-4.
  2. 2. Goldbrunner R, Weller M, Regis J, Lund-Johansen M, Stavrinou P, Reuss D. et al. EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro Oncol. 20. Jan 11;22(1):31-45.
  3. 3. Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol. 2005 Jan;26(1):93-7.
  4. 4. Singh K, Singh MP, Thukral C, Rao K, Singh K, Singh A. Role of magnetic resonance imaging in evaluation of cerebellopontine angle schwannomas. Indian J Otolaryngol Head Neck Surg. 2015 Mar;67(1):21-7.
  5. 5. De Foer B, Kenis C, Van Melkebeke D, Vercruysse JP, Somers T, Pouillon M. et al. Pathology of the vestibulocochlear nerve. Eur J Radiol. 2010 May;74(2):349-58. doi: 10.1016/j.ejrad.2009.06.033. Epub 2010 Mar 27. PMID: 20347243.
  6. 6. Leon J, Lehrer EJ, Peterson J, Vallow L, Ruiz-Garcia H, Hadley A. et al. Observation or stereotactic radiosurgery for newly diagnosed vestibular schwannomas: A systematic review and meta-analysis. J Radiosurg SBRT. 2019;6(2):91-100.
  7. 7. Koos WT, Day JD, Matula C, Levy DI. Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg. 1998 Mar;88(3):506-12. doi: 10.3171/jns.1998.88.3.0506. PMID: 9488305.
  8. 8. Erickson NJ, Schmalz PGR, Agee BS, Fort M, Walters BC, McGrew BM. et al. Koos Classification of Vestibular Schwannomas: A Reliability Study. Neurosurgery. 2019 Sep 1;85(3):409-414.

Ayrıntılar

Birincil Dil

İngilizce

Konular

İç Hastalıkları

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

9 Aralık 2021

Gönderilme Tarihi

17 Ağustos 2021

Kabul Tarihi

1 Aralık 2021

Yayımlandığı Sayı

Yıl 2021 Cilt: 6 Sayı: 3

Kaynak Göster

Vancouver
1.Umut Percem Orhan Soylemez, Başak Atalay, Nesrin Gündüz. The Relationship Between Koos Classification and ADC-Post-Contrast Signal Intensity Values of Vestibular Schwannomas. Arch Clin Exp Med. 01 Aralık 2021;6(3):144-7. doi:10.25000/acem.984043